Legislative intelligence / 90R
SESSION 2027View project ↗

HB 1260: Relating to the disclosure of financial interests by and the regulation of advertising by health care practitioners who promote or facilitate the sale of drugs to consumers; providing administrative and civil penalties.

Session
90th Texas Legislature, Regular Session
Status
Filed
Filed
Nov 20, 2026
Most recent action
11/20/2026 H Filed
Authors
McGee
Official subjects
Business & Commerce--General; Civil Remedies & Liabilities; Health Care Providers; ADVERTISING; MEDICINE & PRESCRIPTION DRUGS; PHARMACIES & PHARMACISTS; TELEMEDICINE; HEALTH PROFESSIONS COUNCIL

AI summary (not official): Requires drug-selling practitioners to disclose financial interests, support health claims, and follow prescribing rules.

Topics: Healthcare, Local government, Business regulation. From AI review or caption rules.

Agencies it could affect (possible, not confirmed): Office of the Attorney General, Health Professions Council, Texas State Board of Pharmacy. From AI review or caption rules.

Laws this bill changes

Bill text (Introduced)

By: McGee H.B. No. 1260

A BILL TO BE ENTITLED

AN ACT

relating to the disclosure of financial interests by and the regulation of advertising by health care practitioners who promote or facilitate the sale of drugs to consumers; providing administrative and civil penalties.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:

SECTION 1.

SHORT TITLE. This Act may be cited as the Practitioner Drug Promotion Transparency Act.

SECTION 2.

Subtitle A, Title 3, Occupations Code, is amended by adding Chapter 118 to read as follows: CHAPTER 118. PROMOTION AND SALE OF DRUGS BY HEALTH CARE PRACTITIONERS

Sec. 118.001. DEFINITIONS. In this chapter:

(1) "Advertising" means any communication made to the public or to a consumer, in any medium, that promotes the purchase or use of a drug, including a statement made on an Internet website, a social media platform, a newsletter, a subscription publication, a podcast, a broadcast, a video, a livestream, an e-mail, or a text message, and including a link, discount code, or other means of directing a consumer to a point of sale.

(2) "Affiliated entity" means a person in which a health care practitioner or a member of the practitioner's immediate family holds a financial interest, including a pharmacy, telemedicine platform, distributor, wholesaler, or online retailer.

(3) "Covered sale" means a sale or dispensing of a drug to a consumer in this state in which a health care practitioner has a financial interest, whether the drug is dispensed under a prescription drug order, under a statewide standing order or protocol, or without a prescription.

(4) "Drug" has the meaning assigned by Section 431.002, Health and Safety Code, and includes a compounded drug.

(5) "Financial interest" means any direct or indirect interest in, or expectation of, remuneration that varies with or is contingent on the sale of a drug, including:

(A) an ownership or investment interest in an affiliated entity;

(B) a commission, affiliate fee, referral fee, royalty, or share of revenue or profit;

(C) compensation attributable to a discount code, tracking link, or similar referral mechanism; and

(D) a consulting, speaking, sponsorship, or licensing fee paid by a person that manufactures, compounds, distributes, or dispenses the drug. The term does not include ownership of less than one percent of the outstanding securities of a publicly traded company, or a reasonable fee for professional services lawfully billed to a patient that does not vary with the patient's purchase of a particular drug.

(6) "Health care practitioner" means an individual licensed, certified, or registered under this title who is authorized to prescribe or order a drug.

(7) "Licensing authority" means the state agency that issued the health care practitioner's license, certification, or registration.

(8) "Unapproved use" means the use of a drug for a disease, condition, or purpose that is not included in the drug's labeling approved by the United States Food and Drug Administration.

Sec. 118.002. APPLICABILITY. This chapter applies to a health care practitioner who, directly or through an affiliated entity or agent, advertises a drug in which the practitioner has a financial interest or facilitates a covered sale, regardless of whether the practitioner has a practitioner-patient relationship with the consumer.

The text continues: full text of HB 1260.

Links

Texas Bill Atlas is an independent research tool, not an official state website.

PLEASE READ

Before you use Texas Bill Atlas

An independent, open-source project. This site is not affiliated with, endorsed by, or operated by the Texas Legislature, the Texas Legislative Council, the Secretary of State, or any state agency.

Data may be incomplete, delayed, or wrong. Bill records are copied automatically from the legislature’s public files. Topic, agency, party, influence and last-action tags, and the full-text summaries written by Luna (an AI model), are automated interpretations and can be mistaken.

Not advice. Nothing here is legal, political, or professional advice. The project and its contributors make no warranty of accuracy or completeness and accept no liability for errors, omissions, or decisions made using this site.

Check the official record. Confirm anything that matters on Texas Legislature Online. Spotted a mistake? Report it on GitHub.

TEXAS BILL ATLAS

Privacy Policy

Last updated: November 11, 2026

Texas Bill Atlas is a free, independent, open-source project. We believe you should be able to research legislation without creating an account or providing personal information.

Information we collect

We do not require registration, names, email addresses, or other personal information to use the service.

We do not sell personal information, serve targeted advertising, or intentionally track individual browsing activity.

Analytics and security

We use Cloudflare for website delivery, security, and traffic analytics.

Cloudflare may process technical information such as IP addresses, browser details, request information, and website usage statistics. Cloudflare may also use cookies necessary for security and abuse prevention.

For more information, see Cloudflare's Privacy Policy.

Watchlists and saved preferences

Watchlists and preferences are stored locally in your browser by default.

If you choose to enable watchlist synchronization, we store the selected bill numbers, the member codes of legislators you follow, your saved searches (their names, search words and filters), filters, and hashed access keys on our server. View-only links show the bill numbers only.

No account or personal information is required. Anyone possessing a valid private access link may access the associated watchlist according to that link's permissions.

You can delete a synced watchlist using its edit access key. Inactive synced watchlists are automatically removed after approximately one year.

Technical data

Our servers may temporarily process IP addresses and request information for security, rate limiting, and reliable operation.

We do not use this information to build individual user profiles.

The site also loads certain external resources, including Google Fonts. Those providers may receive ordinary technical request information.

Third-party services

Links to government websites, GitHub, and other external services are governed by their respective privacy policies.

Changes

We may update this policy as the project develops. The current version will be available on this website with its updated date.

Questions

For questions about the project or its privacy practices, visit our GitHub repository.